Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.
Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.
Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.
PACS's RSI(14) currently reads 48. RSI compares the size of recent up moves to down moves to flag stretched conditions in either direction. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'normal' range. Cross-check this against PACS's other indicators above before drawing a conclusion. → Learn more
ADX currently reads 29. ADX quantifies how strongly a trend is persisting, independent of whether it's up or down (25+ is considered pronounced). Right now PACS shows +DI and -DI show no clear edge either way, putting it in the 'strong trend' range on ADX. Treat this as one data point on PACS, not a standalone signal. → Learn more
PACS's Bollinger Band width is in the bottom 15% (narrow) of its past year, and the squeeze indicator is currently active. A squeeze flags that band width has narrowed to a low percentile versus its own trailing history. A squeeze is often followed by a volatility expansion in either direction. Treat this as one data point on PACS, not a standalone signal. → Learn more
PACS's OBV is currently not showing a clear rise (none), and the up/down volume ratio is 1.3x. OBV adds volume on up days and subtracts it on down days, building a running estimate of money flow. As with any single metric, weigh this alongside PACS's full indicator set. → Learn more
PACS's recent volume is running at 0.6x its usual level. This ratio shows how many times normal volume the stock has been trading at lately — a reference point for whether order flow is concentrating around this stock. Cross-check this against PACS's other indicators above before drawing a conclusion. → Learn more
PACS's change over the last 5 trading days is +1.5%, and over the last 1 trading day is -0.3%. Both are backward-looking price-change figures, not a forecast of future movement.
PACS's current price is 10.6% below its 20-day high. Distance from the recent high is a reference point for how close price is to potential resistance. On this measure it currently falls in the 'distance from high' category. Cross-check this against PACS's other indicators above before drawing a conclusion. → Learn more
PACS's ATR% currently reads 4.5%, a 'daily range' level. ATR captures typical day-to-day volatility in dollar (here, percentage) terms. Cross-check this against PACS's other indicators above before drawing a conclusion. → Learn more
PACS's 20-trading-day relative strength versus SPY (S&P 500 ETF) is -9.8%. A negative relative-strength reading means the stock lagged the broad market. As with any single metric, weigh this alongside PACS's full indicator set. → Learn more
Measured (n=3949), the hit-rate for Bollinger Band Squeeze (28.3%) was not statistically distinguishable from the base rate (29.3%). Cross-check this against PACS's other indicators above before drawing a conclusion. → Bollinger Band Squeeze
No significant edge was measured for Weekly Squeeze: 25.4% versus a 29.3% base rate across 5281 cases. This reading is specific to PACS on this scan date and can change quickly. → Weekly Squeeze
Stocks holding Stage 2 Trend Template reached +15% 21.4% of the time, versus a 29.3% base rate — not a statistically significant difference (1385 cases). As with any single metric, weigh this alongside PACS's full indicator set. → Stage 2 Trend Template
Avg Daily Range 4%+ has a real, measured edge here: 59.5% hit-rate versus a 29.3% base rate, from 2502 observed cases. As with any single metric, weigh this alongside PACS's full indicator set. → Avg Daily Range 4%+
Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (PACS diagnostic as of 2026.08.28 16:04).
A history of past monitoring candidates — not investment advice. See the scanner's full track record here.